Table III.
Duration of delay from initial evaluation | Number of subjects | Coefficient β (SE) | Size ratio (CI)a | p-value |
---|---|---|---|---|
<1 mo | 41 | 0 | 1 | (Reference) |
1–3 mo | 35 | −0.06 (0.22) | 0.9 (0.6–1.4) | 0.8 |
3–6 mo | 41 | −0.10 (0.21) | 0.9 (0.6–1.4) | 0.6 |
6–12 mo | 39 | 0.06 (0.20) | 1.1 (0.7–1.6) | 0.8 |
More than 1 y | 40 | 0.70 (0.22) | 2.0 (1.3–3.1) | 0.0016 |
Unknown | 23 |
Coefficients are standardized with anatomic site, age, histologic subtype, and gender controlled in analysis. The dependent variable was the log of defect size (cm2). p-value is based on F test.
Size ratio is defined by using eβ, e.g. e0.70 =2.0, which clinically represents a doubling of defect size.
CI, confidence interval.